authors
- Namrata Singh, MD MSCI
- Jarvik, Jeffrey
- Heagerty, Patrick J
- Singh, Siddharth
- Gold, Laura S
- Jiha Lee, MD, MHS
- Katherine Wysham, MD
- Andrews, James S
- Una Makris, MD, MSc
- England, Bryant R
- George, Michael D
- Baker, Joshua F
Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted-Synthetic Disease-Modifying Antirheumatic Drugs.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- December 20, 2023
published in
- Arthritis care & research Journal
has subject area
- Adult
- Antirheumatic Agents
- Arthritis, Rheumatoid
- Biological Products
- Databases, Factual
- Female
- Frailty
- Hospitalization
- Humans
- Infections
- Janus Kinase Inhibitors
- Male
- Middle Aged
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Time Factors
- Treatment Outcome
- Tumor Necrosis Factor Inhibitors
- United States